Literature DB >> 25037289

Dementia and cognitive impairment: epidemiology, diagnosis, and treatment.

Julie Hugo1, Mary Ganguli2.   

Abstract

Symptoms of memory loss are caused by a range of cognitive abilities or a general cognitive decline, and not just memory. Clinicians can diagnose the syndromes of dementia (major neurocognitive disorder) and mild cognitive impairment (mild neurocognitive disorder) based on history, examination, and appropriate objective assessments, using standard criteria such as Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. They can then diagnose the causal subtypes of these syndromes using standard criteria for each of them. Brain imaging and biomarkers are making progress in the differential diagnoses among the different disorders. Treatments are still mostly symptomatic.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Biomarkers; Diagnosis; Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); Mild cognitive impairment (MCI); National Institute on Aging–Alzheimer’s Association (NIA-AA) guidelines; Neurocognitive disorder; Risk factors

Mesh:

Year:  2014        PMID: 25037289      PMCID: PMC4104432          DOI: 10.1016/j.cger.2014.04.001

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  104 in total

1.  Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia.

Authors:  Mario F Mendez; Jill S Shapira; Aaron McMurtray; Eliot Licht
Journal:  Am J Geriatr Psychiatry       Date:  2007-01       Impact factor: 4.105

2.  Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Martina Chiappelli; Fausta Montesi; Emanuela Tumini; Erminia Mariani; Federico Licastro; Christopher Patterson
Journal:  Neurobiol Aging       Date:  2006-09-29       Impact factor: 4.673

3.  Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.

Authors:  Kaarin J Anstey; Chwee von Sanden; Agus Salim; Richard O'Kearney
Journal:  Am J Epidemiol       Date:  2007-06-14       Impact factor: 4.897

4.  Inflammation in Alzheimer's disease: insights from immunotherapy.

Authors:  Jonathan M Schott; Tamas Revesz
Journal:  Brain       Date:  2013-09       Impact factor: 13.501

5.  Alcohol consumption and cognitive function in late life: a longitudinal community study.

Authors:  M Ganguli; J Vander Bilt; J A Saxton; C Shen; H H Dodge
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

6.  The vascular depression hypothesis: an update.

Authors:  Joel R Sneed; Michelle E Culang-Reinlieb
Journal:  Am J Geriatr Psychiatry       Date:  2011-02       Impact factor: 4.105

7.  Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication.

Authors:  S Fleminger; D L Oliver; S Lovestone; S Rabe-Hesketh; A Giora
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

Review 8.  An active and socially integrated lifestyle in late life might protect against dementia.

Authors:  Laura Fratiglioni; Stephanie Paillard-Borg; Bengt Winblad
Journal:  Lancet Neurol       Date:  2004-06       Impact factor: 44.182

9.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

Review 10.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Birks
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
View more
  154 in total

1.  Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference.

Authors:  John E Morley; John C Morris; Marla Berg-Weger; Soo Borson; Brian D Carpenter; Natalia Del Campo; Bruno Dubois; Keith Fargo; L Jaime Fitten; Joseph H Flaherty; Mary Ganguli; George T Grossberg; Theodore K Malmstrom; Ronald D Petersen; Carroll Rodriguez; Andrew J Saykin; Philip Scheltens; Eric G Tangalos; Joe Verghese; Gordon Wilcock; Bengt Winblad; Jean Woo; Bruno Vellas
Journal:  J Am Med Dir Assoc       Date:  2015-09-01       Impact factor: 4.669

Review 2.  Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.

Authors:  Almudena Areosa Sastre; Robin Wm Vernooij; Magali González-Colaço Harmand; Gabriel Martínez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-15

Review 3.  Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.

Authors:  Jessay Gopuran Devassy; Shan Leng; Melissa Gabbs; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

4.  Why and how to use mixed methods in primary health care research.

Authors:  Isabelle Vedel; Navdeep Kaur; Quan Nha Hong; Reem El Sherif; Vladimir Khanassov; Claire Godard-Sebillotte; Nadia Sourial; Xin Qiang Yang; Pierre Pluye
Journal:  Fam Pract       Date:  2019-05-23       Impact factor: 2.267

5.  Delirium or Dementia?

Authors:  Steven Lippmann; Malathi Latha Perugula
Journal:  Innov Clin Neurosci       Date:  2016-10-01

6.  Does Low Subjective Social Status Predict Cognitive Decline in Chinese Older Adults? A 4-Year Longitudinal Study From Hong Kong.

Authors:  Jean H Kim; Timothy S Sumerlin; William B Goggins; Elizabeth M S Kwong; Jason Leung; Blanche Yu; Timothy C Y Kwok
Journal:  Am J Geriatr Psychiatry       Date:  2021-01-23       Impact factor: 4.105

Review 7.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

Review 8.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

9.  Sleep-disordered breathing and the risk of cognitive decline: a meta-analysis of 19,940 participants.

Authors:  Xiaoxia Zhu; Yanli Zhao
Journal:  Sleep Breath       Date:  2017-09-13       Impact factor: 2.816

10.  The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity.

Authors:  Nancy A West; Jonathan V Tingle; Jeannette Simino; Elizabeth Selvin; Jan Bressler; Thomas H Mosley
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Apr-Jun       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.